Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
- 25 June 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (1) , 87-99
Abstract
Background Bullous pemphigoid (BP) is associated with significant disability and comorbid health disorders that may lead to or result from hospitalization. However, little is known about the inpatient burden and comorbidities of BP. Objectives To obtain data on the inpatient burden and comorbidities of BP in the U.S.A. Methods We analysed data from the 2002 to 2012 National Inpatient Sample, including a representative 20% sample of all hospitalizations in the U.S.A. (72 108 077 adults). Results The prevalence of hospitalization for BP increased from 25·84 to 32·60 cases per million inpatients from 2002 to 2012. In multivariate logistic regression models with stepwise selection, increasing age, nonwhite ethnicity, higher median household income, being insured with Medicare or Medicaid, and increasing number of chronic conditions were all associated with hospitalization for BP (P < 0·05 for all). The top three primary discharge diagnoses for patients with a secondary diagnosis of BP were septicaemia (prevalence 5·51%, 95% confidence interval 5·03–5·99), pneumonia (4·60%, 4·19–5·01) and urinary tract infection (3·52%, 3·15–3·89). Patients with BP also had numerous autoimmune, infectious, cardiovascular and other comorbidities. Interestingly, BP was associated with multiple neuropsychiatric disorders, including demyelinating disorders, dementias (presenile, senile, vascular and other), paralysis, neuropathy (diabetic, other polyneuropathy), Parkinson disease, epilepsy, psychoses and depression. The mean annual age‐ and sex‐adjusted in‐hospital mortality rate was significantly higher in patients with a secondary diagnosis of BP compared with no BP (2·9%, range 2·8–3·9% vs. 2·1%, range 1·9–2·2%). Significant predictors of mortality in patients with BP included increasing age, nonwhite ethnicity and insurance with Medicaid or other payment status (P < 0·05 for all). Conclusions Hospitalization for BP increased significantly between 2002 and 2012. Moreover, there were significant ethnic and healthcare disparities with respect to hospitalization and inpatient mortality from BP.Keywords
Funding Information
- Agency for Healthcare Research and Quality (K12HS023011)
- Dermatology Foundation
- American Medical Association Foundation
- National Institute for Health Research (NIHR/CS/010/014)
This publication has 14 references indexed in Scilit:
- Costs of Care for Hospitalization for Pemphigus in the United StatesJAMA Dermatology, 2016
- Validation of database search strategies for the epidemiological study of pemphigus and pemphigoidBritish Journal of Dermatology, 2015
- Persistent Racial Disparity in Stroke Hospitalization and Economic Impact in Young Adults in the Buckle of Stroke BeltStroke, 2014
- Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based studyBritish Journal of Dermatology, 2011
- The Relationship between Neurological Disease and Bullous Pemphigoid: A Population-Based Case–Control StudyJournal of Investigative Dermatology, 2011
- A population-based study of acute medical conditions associated with bullous pemphigoidBritish Journal of Dermatology, 2009
- Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort studyBMJ, 2008
- Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?British Journal of Dermatology, 2005
- Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidenceJournal of the American Academy of Dermatology, 1999
- BULLOUS DISEASES IN MALAYSIA: EPIDEMIOLOGY AND NATURAL HISTORYInternational Journal of Dermatology, 1992